Alphabet also remains a popular pick among hedge fund managers. According to Insider Monkey data, 202 hedge fund investors ...

Stocks across Asia lost ground on Monday as worries about Chinese AI company DeepSeek reverberated. The company's discounted R1 model knocked tech stocks, sending the Nikkei ( ^N225) in Japan 0.9% ...

Forbes has released its list of Canada’s best employers of 2025, highlighting the top 300 organizations where people actually ...

The new first-line MCL indication gives Calquence a slice of the market of its own and could spur further growth of the drug, ...

We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...

Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/97.00IgUGEy.js ...

The economic storm facing Chancellor Rachel Reeves showed few signs of easing today after the pound lost further ground ...

Drugmaker GSK has agreed to pay up to 1.15 billion US dollars (£950 million) for a US-based biopharmaceutical company which ...

Credit: Bloomberg via Getty Images. GSK has announced a definitive agreement to acquire IDRx, a US-based biotechnology company specialising in treatments for gastrointestinal cancers, for up to ...

Credit: Anciens Huang/Shutterstock. GSK has gained US Food and Drug Administration (FDA) breakthrough therapy designation (BTD) for its B7-H3-targeted antibody-drug conjugate (ADC), GSK’227, to treat ...

GSK announced that its monoclonal antibody, Nucala (mepolizumab), has been approved in China for treating adults with chronic rhinosinusitis with nasal polyps (CRSwNP), a condition affecting 30 ...

With Canada facing a federal election and multiple challenges in 2025, the At Issue panel answers your political questions as the country heads into what is expected to be a challenging year.